ISDS Releases Meaningful Use Recommendations

The International Society for Disease Surveillance is pleased to present "Electronic Syndromic Surveillance Using Hospital Inpatient and Ambulatory Clinical Care Electronic Health Record Data: Recommendations from the ISDS Meaningful Use Workgroup" (Recommendations). The ISDS Meaningful Use (MUse) Workgroup's Recommendations provide clarity for Stage 2 Meaningful Use, when on-going syndromic surveillance reporting will be required for eligible hospitals. These Recommendations provide a basis for planning and establishing data use relationships between Public Health Agencies and eligible providers while also building upon prior ISDS work by incorporating both lessons learned and broader stakeholder participation.

The Recommendations were developed in an open, iterative, and consensus-driven manner overseen by a multi-stakeholder workgroup of experts in public health, clinical care, medical informatics, and health information technology. Stakeholder feedback was gathered at the initial stages of development as well after Draft Guidelines and Revised Guidelines were released. In the end, 7 organizations and approximately 100 individuals participated in the development process. 

ISDS is grateful to the MUse Workgroup and HLN Consulting, LLC for their shared expertise, talents, and time over the one-year period that the Recommendations were developed. ISDS also thanks the subject matter experts, stakeholders, readers, and ISDS Board of Directors who provided thoughtful help and consideration during this process. Finally, thank you to the Division of Informatics Solutions and Operations, OSELS, CDC for making this work possible. ISDS is grateful for the on-going partnership and support of the CDC in convening the surveillance stakeholder community for expert, consensus recommendations about syndromic surveillance for Meaningful Use. 

Please visit the ISDS website for more information about the Recommendations and their development process.